|
Cognitive status of prostate cancer (PCa) patients aged 60 years and older initiating gonadotropin-releasing hormone agonist (GnRHa) therapy, by age group. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Astellas Pharma; Bouchara Recordati; Ipsen; Janssen; Roche |
Research Funding - AstraZeneca; Roche |
Travel, Accommodations, Expenses - Ipsen; Janssen |
|
|
Consulting or Advisory Role - Arquer Diagnostics; Astellas Pharma; GlaxoSmithKline; Ipsen; Janssen; Roche |
|
Nathalie Pello Leprince Ringuet |
|
Stock and Other Ownership Interests - Ipsen |
Other Relationship - Ipsen |
|
|
|
Stock and Other Ownership Interests - Ipsen |
|
|
Consulting or Advisory Role - Amgen; Ferring; Janssen |
Travel, Accommodations, Expenses - Astellas Pharma; Bouchara Recordati; Ferring; Janssen |